The SOPHiA DDM Platform leverages artificial intelligence for next-generation sequencing (NGS) data synthesis. Credit: National Cancer Institute on Unsplash.

Centre Hospitalier de Bastia, a general hospital in Bastia, Corsica, has gone live on the SOPHiA DDM Platform by Sophia Genetics.

The cloud-based platform leverages artificial intelligence (AI) for next-generation sequencing (NGS) data synthesis.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It will enable the hospital to introduce in-house NGS and support its clinical oncology research, particularly in the field of haematologic malignancies.

Haematologic cancers, such as leukaemia and lymphoma, will be a focus, as the platform helps to categorise disease-associated mutations and provide deeper insights, according to the vendor.

By using the SOPHiA DDM Platform, Centre Hospitalier de Bastia aims to enhance molecular testing capabilities, speed up research efforts, and enable data-driven medicine.

See Also:

SOPHiA GENETICS Business Development and Marketing vice-president Kevin Puylaert said: “Next-generation sequencing has become the gold standard in genomic testing, specifically as it relates to fast-moving and sometimes complex cancers like haematologic malignancies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“By using the SOPHiA DDM Platform, Centre Hospitalier de Bastia is enhancing their research capabilities and connecting with world-class institutions globally, making precision medicine a reality in Corsica.”

Last month, Turkey’s Ankara Etlik City Hospital integrated the SOPHiA DDM Platform to streamline its genomic research workflow and establish an in-house database of genomic data and insights.

This database is aimed at enhancing research efficiency and enabling experts to make data-driven decisions.